| WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy S Qi, Y Zhu, X Liu, P Li, Y Wang, Y Zeng, A Yu, Y Wang, Z Sha, Z Zhong, ... Molecular Cell 82 (10), 1850-1864. e7, 2022 | 63 | 2022 |
| The Hippo signaling pathway in development and regeneration Z Zhong, Z Jiao, FX Yu Cell Reports 43 (3), 2024 | 44 | 2024 |
| Two Hippo signaling modules orchestrate liver size and tumorigenesis S Qi, Z Zhong, Y Zhu, Y Wang, M Ma, Y Wang, X Liu, R Jin, Z Jiao, R Zhu, ... The EMBO journal 42 (11), e112126, 2023 | 30 | 2023 |
| Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy X Peng, S Zhang, W Jiao, Z Zhong, Y Yang, FX Claret, M Elkabets, ... Journal of Experimental & Clinical Cancer Research 40, 1-21, 2021 | 19 | 2021 |
| Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair X Peng, S Zhang, Y Wang, Z Zhou, Z Yu, Z Zhong, L Zhang, ZS Chen, ... Advanced Science 10 (3), 2205529, 2023 | 15 | 2023 |
| Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers Y Gu, Y Wang, Z Sha, C He, Y Zhu, J Li, A Yu, Z Zhong, X Wang, Y Sun, ... Cell Reports 40 (9), 2022 | 15 | 2022 |
| WWC1/2 regulate spinogenesis and cognition in mice by stabilizing AMOT R Cao, R Zhu, Z Sha, S Qi, Z Zhong, F Zheng, Y Lei, Y Tan, Y Zhu, ... Cell Death & Disease 14 (8), 491, 2023 | 10 | 2023 |
| Reconstructing the Hippo signaling network Z Zhong, Z Meng, FX Yu Science bulletin 68 (20), 2307-2310, 2023 | 9 | 2023 |
| Phosphorylation of NF2 at Serine-13 by MAP4K family kinases mediates pathological angiogenesis M Ma, Z Zhong, Y Zhu, Y Gu, R Jin, Z Meng, Y Wang, FX Yu Protein & cell 14 (2), 137-142, 2023 | 6 | 2023 |
| Gene therapy for diffuse pleural mesotheliomas in preclinical models by concurrent expression of NF2 and SuperHippo R Zhu, X Liu, X Zhang, Z Zhong, S Qi, R Jin, Y Gu, Y Wang, C Ling, ... Cell Reports Medicine 5 (10), 2024 | 4 | 2024 |
| JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway L Zhang, YY Yang, L Xie, Y Zhou, Z Zhong, J Ding, ZH Wang, YL Wang, ... Clinical and Translational Medicine 14 (3), e1630, 2024 | 3 | 2024 |
| WWC proteins–mediated compensatory mechanism restricts schwannomatosis driven by NF2 loss of function X Wang, R Zhu, P Yu, S Qi, Z Zhong, R Jin, Y Wang, Y Gu, D Ye, K Chen, ... Science Advances 11 (4), eadp4765, 2025 | | 2025 |
| Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma X Peng, X Huang, S Zhang, N Zhang, S Huang, Y Wang, Z Zhong, S Zhu, ... Advanced Science 11 (30), 2307747, 2024 | | 2024 |
| Abstract LB272: Sequential inhibition of PARP and BET as a rational therapeutic strategy for glioblastoma multiforme X Peng, X Huang, S Zhang, N Zhang, S Huang, Y Wang, Z Zhong, S Zhu, ... Cancer Research 84 (7_Supplement), LB272-LB272, 2024 | | 2024 |
| Spatiotemporally restricted Hippo signalings instruct the fate and maturation of hepatobiliary cells Y Wang, Z Zhong, Y Wang, Y Zhu, KL Guan, FX Yu bioRxiv, 2024.11. 02.621695, 2024 | | 2024 |
| IGF2 mediates Hippo signaling to control liver size Z Zhong, R Jin, Y Zhong, L Zhang, D Chen, Z Jiao, F Zhou, R Zhu, J Wu, ... bioRxiv, 2024.10. 27.620455, 2024 | | 2024 |
| Research progress in targeting homologous recombination repair for tumor therapy Z Zhong, X Peng, D Kong Yao Xue Xue Bao, 2535-2548, 2020 | | 2020 |